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NLC systems are the second generation of innovative lipid nanoparticles serving as bioactive carrier systems. NLCs consisting of a mixture of liquid and solid lipids have been developed to overcome some potential limitations of solid lipid nanoparticle [9, 10] . Among the major advantages of NLCs is increased stability and drug-loading capacity, as well as preventing the discontinuation of the drug during storage [11, 12] .
Chitooligosaccharides (COS) are chitosan or chitin disruption products prepared by enzymatic or chemical hydrolysis of chitosan. As mentioned in the literature, chitosan and its derivatives have valuable traits that make it possible to apply in many areas, such as food, cosmetics, biomedicine and agriculture. It is also important in the field of drug development owing to its biodegradable, non-toxic and non-allergic nature [13] . In addition, based on their highly positive electric charges, they play a major role in gene delivery [14] [15] [16] . COS has a low molecular weight and is highly soluble in water because of their short chain lengths and free amino groups in their D-glucosamine units. In addition, they are readily absorbed by the human intestines. With this, oligosaccharides have recently become more and more attractive to researchers because they are biocompatible and biodegradable, like chitosans [13, 17] .
In this study, the aim was to develop a gene carrier system that is biodegradable, at the nanoscale and having high transfection efficiency. For this reason, nanostructured lipidic formulations with different surfactants have been prepared and coated with chitooligosaccharide. As a result, nanoparticles with low nanoparticle size, relatively high zeta potential and high transfection efficiency were prepared. As a consequence of their six-month stability, no significant change was observed in their size, zeta potential or DNA-binding properties.
RESULTS AND DISCUSSION
The application of gene therapy in various diseases has attracted attention for the last two decades. After a series of lethal events, most of which were based on the use of viral vectors and because most immunogenic reactions or mutations were caused by viruses, gene therapy has experienced a strong suppression owing to safety concerns. However, significant advances have been made thanks to technological and scientific developments, and so non-viral delivery systems have been utilised in the transport of genetic materials over the years [20] .
Additionally, the FDA's approval and market launch of a variety of biological pharmaceuticals, including antibodies and genetic materials, support the potential for improvement strategies of these transport systems. Therefore, the formulation of transport systems for biological molecules has become an important area. In this study, we leveraged the advantages of NLC systems and the natural cationic properties of chitosan to develop a more efficient gene delivery system.
Characterisation studies
Physicochemical properties, such as particle size, size distribution, shape, solubility and surface charge, factor prominently in biological processes, including biodistribution, toxicity and cellular uptake of nanoparticles [21] .
Nanoparticle size and size distribution was determined by dynamic light scattering with a particle size analyser (Malvern Zeta Sizer Nano ZS) at a constant angle of 175° at 25 °C. Size distribution was established through the polydispersity index. The smaller these values were evaluated, the narrower the size distribution or the uniformity of the prepared nanoparticles. The data on particle size, size distribution (PDI), pH and zeta potential are reported in Table 1 , representing the average of three measurements. During preliminary studies of the formulations, particle sizes between 255-523 nm were determined before filtration. It was noted that small particle size increases stability and decreases toxicity [22] .
Therefore, filtering was effective in reducing these dimensions. So, the particle sizes of the prepared formulations were below 200 nm. The particle distribution in the dispersion was also assessed as relatively homogeneous.
The debate surrounding the optimum size required for cellular uptake in the literature is still ongoing. In one study, it was stated that a particle size of 100-500 nm was optimal for lymphatic uptake via the GI lymphatic system, but smaller particles were slow to receive [23] . It has been put forth that nanoparticles with a diameter of 100 nm engage in cellular uptake 2.5-fold greater than 1-micron diameter particles in Caco-2 cells [24] . In another investigation, it was stated that 50-nm nanoparticles were more efficiently internalized and had a higher uptake rate whereas there was a decreased cellular uptake for smaller or larger particles [25] . Cell type is also significant in the recruitment of nanoparticles. For example, in hepatic cell lines, such as Hep G2 and Hepa 1-6, nanoparticles between 93 and 220 nm dimensions can be internalized, while much larger particles, up to 1 micron, are effectively internalized by HUVEC, HNX 14C and ECV 30 cell lines [26] . In this study, the particle sizes of all formulations were in the range of 115 ± 1.3 and 189 ± 0.55 nm. Most researchers recognize PDI values ≤ 0.3 as optimum values; however, values ≤ 0.5 are also acceptable. For polydisperse systems, the PDI should be less than 0.5. The PDI value of all formulations ranged between 0.115 ± 0.12 and 0.301 ± 0.05 ( Table 1) , indicating that the formulations are polydisperse systems with relatively homogenous size distributions. The zeta potential is the measure of the total loads obtained by particles in a given environment and is the second main characterisation tool to assist in understanding formulation stability. In the literature, if the zeta potential is above 30 mV, it is notable that the distribution system provides robust stability, whereas below 30 mV, it leads to instability [27, 28] . In transporting the genetic material, it is necessary to create an electrostatic interaction between the pDNA and particles. So, nanoparticles should have a specific zeta potential and therefore be capable of binding to the cell membrane as a result of it [29, 30] . According to the zeta analysis results, it was determined that those particles coated with COS have a suitably high zeta potential values and stability for interactions with cell membranes.
The morphology of the particles was analysed using SEM. When reviewing the SEM images, prepared COS-coated formulations had spherical particles featuring rough as well as smooth surfaces (Figure 1 ). 
Gel Retardation Assay
The gel retardation studies were performed for controlling DNA-nanoparticle interactions and learning the effects of serum and DNAse. Understanding the interaction of DNA/nanoparticles with physiological fluids is critical to their use for in vivo delivery. The amount and size of the genetic material, the coating material of the carrier system used or the adsorption/encapsulation of genetic material are important parameters for protection against DNAse endonucleases [31] .
DNA-binding properties of F1/COS and F2/COS formulations were established using gel documentation systems. For this reason, 0.5 µg pGFP DNA and between 0.05-2% w/w concentration ratios were used. The complexes were observed on the gel after incubation for 15 min at 37 °C to attain electrostatic interactions. It was observed that the formulations could bind effectively at all studied concentrations.
As it can be seen in Figure 2 , the high positive charges of COS-coated formulations appear to neutralize the negative charges of phosphate groups in the DNA backbone, thereby inhibiting the movement of DNA from the well. It is obvious that lipidic nanoparticles have a negative charge unless a cationic lipid is added or coated with a positive charge, such as that with chitosan. Therefore, no binding studies were carried out on them in this study. In vivo administration of naked DNA is not possible owing to cleavage by nucleases in blood circulation. Thus, the formulations prepared should protect DNA against both serum components (lipases, high density lipoproteins, etc.) and nucleases [32, 33] .
When the F1/COS/DNA and F2/COS/DNA were treated with 10% serum, the complexes began to dissociate in very small amounts at six hours onwards with almost complete dissociation after 48 hours ( Figure  2C and 2D).
Cell viability and transfection
Nanoparticulate systems are necessary for gene transport, but these systems cannot be used if the genetic material is not able to enter the cell or be released effectively. As the size of the developed particles becomes smaller, the ratio of surface area to volume rises. This means that the drug is closer to the particle surface of a small molecule than a large molecule. Being on or near the surface will lead to faster drug release [23] . The formulation of nanoparticle systems with a large surface area/volume ratio is hence very important. However, as size may affect cytotoxicity, optimum properties should be determined [20, 34] .
In vitro cell viability and transfection efficacy analysis were carried out in NIH-3T3, A549 and MDA-MB 231 cells, in particular with both normal and cancer cell types. The reason for this was to reveal the possible differences in cell viability or transfection and how this affects such cells. As can be seen in Figure 3 , the cell viabilities of formulations exhibited dose-and time-dependent patterns compared with controls.
The formulations without COS coating were identified as the most effective on cells. F1 formulations also influenced cell viability at lower doses than F2 (p<0.1). At the end of a 24-hour incubation period, the IC 50 values for 100 µL were observed as 17 µg ± 2.2, 20 µg ± 3.2 and 17 µg ± 4.3 for F1 and 27 µg ± 1.8, 33 µg ± 2.1 and 58 µg ± 0.6 for F2 formulations in 3T3, A549, MDA-MB cells, respectively. At the end of a 48-hour incubation period, the IC50 values for 100 µL were observed as 14 µg ± 3.3, 16 µg ± 2.0 and 20 µg ± 3.1 for F1 and 15 µg ± 1.6, 19 µg ± 2.7 and 20 µg ± 3.5 for F2 formulations.
When examining COS-coated formulations, the IC50 values for 100 µL were observed at 24 µg ± 1.5, 48 µg ± 2.7 and 50 µg ± 3.9 for F1/COS and 55 µg ± 2.2, 55 µg ± 5.7 and 63 µg ± 2.6 for F2/COS formulations in 3T3, A549, MDA-MB cells, respectively. Moreover, at the end of the 48-hour incubation, the IC50 values for 100 µL were observed as 15 µg ±4.4, 30 µg ± 3.8 and 35 µg ± 1.6 for F1/COS and 30 µg ± 6.6, 32 µg ± 3.5 and 50 µg ± 3.4 for F2/COS formulations. The hydrophilicity of molecules also impacts cellular uptake. For example, hydrophobic nanoparticles have rapid clearance owing to their greater interaction with blood components, whereas the high hydrophilicity of nanoparticles decreases clearance by preventing hepatic and kidney localisation. Therefore, it is important to cover nanoparticles with polymers and surfactants [23] . Ultimately, it was observed that our formulations are suitable for the aforementioned transfection process -the complexes delivered DNA more easily into cells.
Stability studies
Stability studies were carried out at 30 ±2 ºC/65 ±5% RH for a period of six months. The mean particle size, polydispersity index, zeta potential and DNA-binding capacity of the formulations were determined as a function of storage time. The results of these observations were presented in Table 2 and Figure 5 . According to the results, it was observed that there was no significant difference in particle size, PDI and DNA-binding activity of F2/COS nanoparticles stored for 60 days. However, for the F1/COS formulations, the particle size and polydispersity index increased. Nevertheless, DNA-binding capacity did not become reduced. At the end of six months, no visible changes were observed in F2/COS while the F1/COS formulations were present in an agglomeration at the bottom of the tube that could be dispersed via simple shaking. Considering that the only difference between the two formulations is the surfactants used, it was concluded that the surfactants employed have an effect on the characterisation properties of the particle during storage. In the literature, the importance of surfactants in nanoparticle decorations [35] , the reduction of particle size [36] , preservation of stability [37] and the significance of preventing coalescence [38] are indicated. In our study, the effect of the surfactant is clearly evident.
CONCLUSION
Lipid systems, which can be prepared with solid or liquid lipids, are rapidly gaining researchers' attention thanks to their potential. As a consequence of their ease of use and efficiency, the addition of biodegradable polymeric systems, such as chitosan, increases the availability of these delivery systems. It also reduces the cytotoxicity of lipidic structures. In this study, chitooligosaccharide lactate-coated lipidic nanoparticle dispersions with small particle size and long-term physical stability were successfully prepared using a hot emulsification technique. We believe that the formulations prepared herein are promising carrier systems with relatively small particle sizes, high zeta potentials, effective DNA-binding rates and robust transfection properties for genetic materials that can be applied to the treatment of a wide range of generelated diseases, such as cancers, hereditary diseases and infectious diseases.
MATERIALS AND METHODS
Chitooligosaccharide lactate (Cat no: 523682) was used as polymer and were purchased from Sigma Aldrich (Germany). Dynasan ®116 from IOI Oleo GmbH and Transcutol ® P from Gattefosse (France) were kind gift. As a surfectants, Span ® 60 (Cat no: 7010) and PF127 (Cat no:2443) were obtained from Sigma Aldrich (Germany), Span ® 80 (Cat no:85548) was obtained from Fluka (Germany), and Tween ® 20 (Cat no:817072) was obtained from Merck (Darmstadt, Germany). gWiz-GFP plasmid (Cat no: 90659) for transfection was purchased from Aldevron (North Dakota, USA). Lipofectamine ® 2000 (Cat no: 116-68) used as the reference transfection agent was supplied by Invitrogen (Paisley, UK). DMEM (Cat no: D5796) , fetal bovine serum (Cat no:F4135), agarose (Cat no:9539), Penicillin and streptomycin solution (Cat no: P4333), tyripsin/EDTA solution (Cat no: T4049), and ethidium bromide (Cat no: E1510) were obtained from Sigma Aldrich (Germany). Ultrapure water was obtained using a MilliQ system (Millipore, Bedford, MO, USA). The ultrapure water used in all studies was used after autoclaved.
Preparation of the LNPs
Lipid nonoparticles (LNPs) were prepared by using oil-in water hot emulsification technique, with some modifications [39] . In this technique, weighed amount of solid lipid (Dynasan ® 116) and liquid lipid (Transcutol ® P) were heated to the temperature of 10 °C above the melting point of solid lipid (∼70 °C), and the molten lipid was dispersed in the hot surfactant solution (Tween ® 20, Span ® 80, Span ® 60, Pluronic ® F127) of the same temperature by high-speed stirring at 15.000 rpm using an Ultra Turrax (IKA T-25, USA), and further homogenized for 5min. The hot dispersion was filtered through a 0.22 non pyrogenic filter. Ratios of formulations prepared are shown in Table 3 . 
Coating with COS of LNPs
For the preparation of chitooligosaccharide (COS) coated LNPs, 2.5 mL of the previously prepared and lipidic formulation was slowly added to 10 mL of COS solution 4% (w/v) (in 1xPBS) under magnetic stirring via drop-wise carefully. The droplets were dropped with a 1000µL micropipette in 2.5 minutes at 500 rpm. The mixture was further stirred for 1 hour. The formulations were centrifuged for 10 min at 8000 rpm to remove the free COS from formulation. Supernatants were carefully removed and pellets were redispersed in autoclaved distilled water.
The obtained lipid nanoparticles uncoated and COS coated LNPs were stored in sealed containers at room temperature and 30°C for further analyses. The prepared formulations were named as F1/COS and F2/COS.
Characterization of the LNP's and coated LNP's

Particle size and zeta potential
Particle size, the particle size distribution via the polydispersity index (PI) and zeta potential was analysed by a Zetasizer NanoZS (Malvern Instruments, UK). The measurements were carried out using a suspension of the nanoparticles in 50 µS distilled water. All measurements were determined in triplicates and the average values were considered [30] .
pH measurement
pH value of formulations was measured with ThermoScientific Orion Star pH meter (USA) at room temperature [19] .
Adsorption of plasmid to cLNPs
Specific amounts of GFP were mixed with cationic COS coated LNPs. Those complexes were then incubated at 37 • C for 20 minutes to maintain electrostatic interaction between GFP and positively charged particles. GFP binding properties were visualised with gel retardation assay [19, 30] .
Gel Retardation Assay
Gel retardation studies were used to determine GFP binding efficiency to formulations and the possible degradation in serum, and also to observe adsorbtion efficiency for at the end of 6 months. Samples were loaded on a 1,5 % agarose gel with ethidium bromide staining and electrophoresis was performed for 2 h at 50 V with Tris/Acetate/EDTA (TAE) buffer. The bands properties on the gel was evaluated using a gel documentation system (Uvitec Alliance 4.7, Cambridge, UK) [19] .
Stability in serum
Aiming for the maximum efficiency in cells, formulations prepared must protect GFP against the serum components and also nucleases. Therefore, formulation containig GFP were incubated at 37°C for 1, 4, 10, 24 and 48h with Dulbecco's Modified Eagle Medium (DMEM) which contained 10 % Fetal Bovine Serum (FBS). Images of samples were taken using a gel retardation assay at the end of the period. At the end of the time intervals, samples were loaded to 1,5% agarose gel for 1 hour at 75 volts. Images were obtained using a gel documentation system (Uvitec Alliance 4.7, Cambridge, UK) [19] .
Scanning electron microscope characterization
COS coated formulations analysed by ZEISS Ultra Plus Scanning Electron Microscopy (SEM) for morphological properties. Briefly, the formulations suspended in water and applied it to carbon-coated SEM stabs, was dried it in the air. Afterward, the stub containing the sample was coated with the gold film at 45 s under 30 mA and placed into the scanning electron microscopy (SEM) Chamber. The photos were taken at acceleration voltage of 5 kV.
Stability studies
Stability studies of the DNA-free formulations were performed for 6 months. The samples were evaluated for the intermediate stability studies in accordance with the ICH guidelines. Fort his purpose, the samples were kept at 30 °C ± 2 °C temperatures and 65 ± 5% relative humidity for a period of 180 days stability of the all formulations was monitored periodically time periods, i.e. 0, 30, 90, and 180 days, evaluating aggregation or phase separation, DNA binding efficiency, particle size and zeta potential [18] .
Cell culture
NIH-3T3 (mouse embryo fibroblast), A549 (human lung adenocarcinoma) and MDA-MB-231 (human breast adenocarcinoma) cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic [streptomycin (100 μg/mL)/ penicillin (100 IU/mL)] . Cells were grown at 37 °C with 5 % CO2 in air and subcultured.
Cell viability assay
The cell viability effects of our formulations were determined. Therefore, colorimetric MTT method was used for the quantitative determination of cell viability [40] . NIH-3T3, A549 and MDA-MB-231 cells were used in the method. Absorbance of the plate was measured at 570 nm using a spectrometric microplate reader (BioTek, Cytation 5, England). Analyses were repeated in triplicate. Only cell culture medium contain wells were used as a control. Results were expressed as the percentage of inhibition compared to control cells where cell survival was presumed 100 % [19] .
In vitro transfection efficiency measurement
For the cellular uptake study, cells in a 6-well plate were seeded with antibiotic free medium and incubated at 37 • C for 24h, with 5% CO2 incubator. After reaching the desired cell density (70-90 %), formulations containing 1µg lipid in total were mixed with pGFP (2.5 µg), then the composed complex mixed with antibiotic/FBS-free medium, and added to each well. After 24 hour incubations, plates were examined under a fluorescent microscope. Transfection efficacy of formulations were compared with Lipofectamine ® 2000. A total of about 10000 cells (transfected and non-transfected) at each 20 different areas in the wells were counted. Transfection index (TI) was calculated using the following equation (Eq. 1) [19] ; (Eq. 1)
Statistical analyses
The data of MTT assay was presented as mean and standard deviation on the graphic. The differences between the treated groups and the control groups were analysed from concentration-effect-time curves using linear regression analysis with Minitab 18.and p value less than 0.05 was considered statistically significant.
